Major Depression Clinical Trial
— DIAMONDOfficial title:
DIAMOND Study: Evaluation of a Natural Experiment to Improve Statewide Depression Care in MN
Verified date | July 2014 |
Source | HealthPartners Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
The study will evaluate a unique natural experiment that aims to transform the primary care
of patients with depression. The experiment's aim is to cause statewide implementation of an
evidence-based care model for depression by changing the reimbursement system and by using
an established regional collaborative (the Institute for Clinical Systems Improvement) to
both facilitate the model's widespread use and certify that medical groups have implemented
it. Study hypotheses include the following:
1. Newly treated depressed patients in medical groups that have implemented the new
reimbursement and facilitation will report receiving higher rates of best care
processes than such patients in these medical groups before implementation.
2. Rates of best care practices reported to be received by newly treated depressed
patients two years after each medical group implements changes will be maintained at
least at the rate reported by patients one year post implementation.
3. Newly treated depressed patients in medical groups that have participated in the new
reimbursement and facilitation will have greater improvement in depression symptoms and
work productivity and lower healthcare costs than such patients in groups before
participation.
4. Medical group measures of priority for improving depression care, capability to manage
change, and practice systems will be predictive of more patient-reported best care
processes, both at one point in time and in change over time.
Status | Completed |
Enrollment | 2631 |
Est. completion date | February 2014 |
Est. primary completion date | June 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - major depression - Patient Health Questionaire (PHQ-9) > 9 - primary care management of depression Exclusion Criteria: - comorbid psychiatric conditions |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
HealthPartners Institute | National Institute of Mental Health (NIMH) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rates of best care processes | baseline, 6 months | No | |
Secondary | Improvement in depression symptoms, work productivity and total healthcare costs | baseline, 3 months, 6 months, 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03062150 -
Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression
|
N/A | |
Completed |
NCT04352101 -
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
|
Phase 4 | |
Completed |
NCT02855918 -
Blood Biomarkers in Suicidal Behaviour
|
N/A | |
Recruiting |
NCT03039387 -
Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients
|
N/A | |
Recruiting |
NCT02213016 -
Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients
|
Phase 4 | |
Completed |
NCT01636791 -
CBT Versus a Return to Work Intervention for Patients With Common Mental Illness in Primary Care
|
Phase 3 | |
Completed |
NCT01683539 -
Understanding How Cognitive Remediation Works
|
N/A | |
Recruiting |
NCT02237937 -
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
|
Phase 4 | |
Completed |
NCT01201148 -
Open Pilot Trial of TES for Depression
|
Phase 2 | |
Completed |
NCT00953108 -
Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients
|
Phase 3 | |
Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
Completed |
NCT00806143 -
Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression
|
Phase 4 | |
Terminated |
NCT01244711 -
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
|
Phase 4 | |
Terminated |
NCT00695552 -
The Effect of Exercise on Depressive Symptoms in Unmedicated Patients
|
N/A | |
Completed |
NCT00466323 -
The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.
|
N/A | |
Completed |
NCT00482482 -
Yoga in Unipolar and Bipolar Disorders
|
N/A | |
Completed |
NCT00532480 -
Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine
|
Phase 4 | |
Completed |
NCT00616759 -
The Effect on Cognition of Terminating ECT Induced Seizures With Propofol
|
N/A | |
Recruiting |
NCT00209807 -
Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
|
Phase 4 | |
Completed |
NCT00167310 -
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
|
Phase 2 |